Fundraising FoxParagon Biosciences Emalex Capital, Inc.
Chicaco, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into Paragon Biosciences Emalex Capital, Inc.
162 people in our graph can introduce you to the Paragon Biosciences Emalex Capital, Inc. team.
Sign up to see every warm intro you have to Paragon Biosciences Emalex Capital, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paragon Biosciences Emalex Capital, Inc. team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PJ
Patrick J. MorrisExecutive
EM
Eric MessnerExecutivewith experience forming and leading companies, managing pharmaceutical commercial teams, and overseeing product development, financing, and business development activities.
DP
Darien ParhadExecutive
JA
Jeffrey AroninNamed on SEC filing
TC
Timothy CunniffNamed on SEC filing
Board
AG
Antonio GraciasBoard directorFounder, Chief Executive Officer & Chief Investment Officer at Valor Equity Partners
RS
Ricky SunBoard director
JD
Jeffrey DaynoBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$376.8M disclosed across 5 rounds · 2018–2022
▶$270MraisedJul 2025 · 42 investors · PharmaceuticalsRule 506(b)
▶$270MraisedJul 2025 · 42 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Patrick J. MorrisExecutive Officer
- Jeffrey AroninDirector
- Antonio GraciasDirector
- Eric MessnerExecutive Officer, Director
- Ricky SunDirector
- Jeffrey DaynoDirector
- Darien ParhadExecutive Officer
- Offering amount
- $270M
- Amount sold
- $270M
- Minimum investment
- $1.1K
- Sales commissions
- $5.7M
- Placement agents
- Paragon Health Capital, LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedNov 2022 · 35 investors · PharmaceuticalsRule 506(b)
▶$25MraisedNov 2022 · 35 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Antonio GraciasDirector
- Darien ParhadExecutive Officer
- Jeffrey AroninExecutive Officer, Director
- Patrick J. MorrisExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- Minimum investment
- $3K
- Sales commissions
- $172K
- Placement agents
- Paragon Health Capital, LLC
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$35MraisedMar 2021 · 21 investors · PharmaceuticalsRule 506(b)
▶$35MraisedMar 2021 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey AroninDirector
- Darien ParhadExecutive Officer
- Patrick MorrisExecutive Officer, Director
- Antonio GraciasDirector
- Offering amount
- $35M
- Amount sold
- $35M
- Minimum investment
- $53.5K
- Sales commissions
- $1.5M
- Placement agents
- Paragon Health Capital, LLC
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$37.4MraisedOct 2019 · 10 investors · PharmaceuticalsRule 506(b)
▶$37.4MraisedOct 2019 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Antonio GraciasDirector
- Jeffrey AroninDirector
- Patrick MorrisExecutive Officer, Director
- Offering amount
- $37.4M
- Amount sold
- $37.4M
- Minimum investment
- $31.1K
- Sales commissions
- $1.1M
- Placement agents
- Paragon Health Capital, LLC
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$9.4MraisedDec 2018 · 31 investors · PharmaceuticalsRule 506(b)
▶$9.4MraisedDec 2018 · 31 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Darien ParhadExecutive Officer
- Jeffrey AroninDirector
- Timothy CunniffDirector
- Patrick MorrisExecutive Officer, Director
- Offering amount
- $9.4M
- Amount sold
- $9.4M
- Minimum investment
- $12.5K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Paragon Biosciences Emalex Capital, Inc.'s investors?
- Paragon Biosciences Emalex Capital, Inc.'s investors include Valor Equity Partners.
- How much funding has Paragon Biosciences Emalex Capital, Inc. raised?
- Paragon Biosciences Emalex Capital, Inc. has disclosed $376.8M raised across 5 rounds.
- Where is Paragon Biosciences Emalex Capital, Inc. headquartered?
- Paragon Biosciences Emalex Capital, Inc. is headquartered in Chicaco, US.